JPS525764A - Production of pyrrolidone - Google Patents

Production of pyrrolidone

Info

Publication number
JPS525764A
JPS525764A JP51075954A JP7595476A JPS525764A JP S525764 A JPS525764 A JP S525764A JP 51075954 A JP51075954 A JP 51075954A JP 7595476 A JP7595476 A JP 7595476A JP S525764 A JPS525764 A JP S525764A
Authority
JP
Japan
Prior art keywords
pyrrolidone
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51075954A
Other languages
English (en)
Japanese (ja)
Inventor
Barutoman Biruherumu
Kunsutoman Rudorufu
Reruhi Ururitsuhi
Shierukensu Berunbaruto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS525764A publication Critical patent/JPS525764A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP51075954A 1975-06-27 1976-06-26 Production of pyrrolidone Pending JPS525764A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528664 DE2528664A1 (de) 1975-06-27 1975-06-27 Pyrrolidone und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
JPS525764A true JPS525764A (en) 1977-01-17

Family

ID=5950059

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51075954A Pending JPS525764A (en) 1975-06-27 1976-06-26 Production of pyrrolidone

Country Status (14)

Country Link
JP (1) JPS525764A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT365575B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE843505A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH623809A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2528664A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK287476A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES449095A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2316943A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1553595A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL49916A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU75235A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7606773A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE7607331L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA763802B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
JP2011116768A (ja) * 2002-05-14 2011-06-16 Allergan Inc 眼圧降下剤としての8−アザプロスタグランジン類似体

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE423813B (sv) * 1976-08-06 1982-06-07 Pfizer Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
CN1413190A (zh) * 1999-12-22 2003-04-23 辉瑞产品公司 治疗骨质疏松的ep4受体选择性激动剂
PT1339678E (pt) 2000-11-27 2007-11-30 Pfizer Prod Inc Agonistas selectivos do receptor ep4 no tratamento de osteoporose
RU2288913C2 (ru) 2001-07-16 2006-12-10 Ф.Хоффманн-Ля Рош Аг Аналоги простагландинов, способ их получения и фармацевтическая композиция, обладающая селективной агонистической активностью в отношении рецептора ep4
JP4211605B2 (ja) 2001-07-16 2009-01-21 小野薬品工業株式会社 プロスタノイドアゴニストとしての2ピロリドン誘導体
IL159996A0 (en) 2001-07-23 2004-06-20 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
EP1487437B1 (en) * 2002-03-18 2006-08-16 Pfizer Products Inc. Use of selective ep4 receptor agonists for the treatment of diseases
JP2006515015A (ja) 2003-01-10 2006-05-18 エフ.ホフマン−ラ ロシュ アーゲー プロスタグランジンアゴニストとしての2−ピペリドン誘導体
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
CA2879507A1 (en) 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
US9914725B2 (en) 2013-03-15 2018-03-13 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
ES2635635T3 (es) 2013-03-15 2017-10-04 Cayman Chemical Company, Incorporated Compuestos de difluorolactama como agonistas selectivos del receptor EP4 para su uso en el tratamiento de enfermedades y afecciones mediadas por EP4
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
JP2011116768A (ja) * 2002-05-14 2011-06-16 Allergan Inc 眼圧降下剤としての8−アザプロスタグランジン類似体

Also Published As

Publication number Publication date
IL49916A0 (en) 1976-08-31
DK287476A (da) 1976-12-28
DE2528664A1 (de) 1977-01-13
CH623809A5 (en) 1981-06-30
NL7606773A (nl) 1976-12-29
FR2316943B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-11-03
SE7607331L (sv) 1976-12-28
ZA763802B (en) 1977-05-25
ATA467976A (de) 1981-06-15
AT365575B (de) 1982-01-25
FR2316943A1 (fr) 1977-02-04
BE843505A (fr) 1976-12-28
ES449095A1 (es) 1977-12-16
GB1553595A (en) 1979-09-26
LU75235A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-03-16

Similar Documents

Publication Publication Date Title
JPS51118763A (en) Production of alkylenecarbonate
JPS5236683A (en) Production of riphamycin
JPS525764A (en) Production of pyrrolidone
JPS5212162A (en) Production of phenylindoline
JPS51141897A (en) Production of riphamycin
JPS5251392A (en) Production of triazolopyridazinones
JPS51131873A (en) Production of 44loneralkyll 55cyanoooxazole
JPS527958A (en) Production of 22 pyrrolidone
JPS5248698A (en) Production of riphamycin
JPS525762A (en) Production of betaa acylpyrol
JPS5273865A (en) Production of novel pyrrolidone
JPS51115473A (en) Production of lower alkylimidazolecarboxylate
JPS5289667A (en) Production of nnsubstituted spirolaltam
JPS5219695A (en) Production of tetrahydrothiopyranopyrazols
JPS51115465A (en) Production of 55phenyll 22framidoxime
JPS5227758A (en) Production of 22methyll 11naphthol
JPS5248689A (en) Production of pyrazolopyridineketones
JPS51130543A (en) Production of instant onigiri
JPS5248662A (en) Production of 44hydroxymethyll 22pyrorysines
JPS5273858A (en) Production of phospholenee 11calcogenite
JPS5236690A (en) Production of 33methoxymethlcephalosporin
JPS5246100A (en) Production of pyrazolopyridopirimidine
JPS5212991A (en) Production of bioprotein
JPS51128997A (en) Production of pyrazolopyridineketones
JPS5265286A (en) Production of epsilonn caprolactam